Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) shot up 5.8% on Wednesday . The stock traded as high as $23.47 and last traded at $23.31. 3,429,492 shares were traded during mid-day trading, a decline of 50% from the average session volume of 6,837,543 shares. The stock had previously closed at $22.04. Analyst […]
Mckinley Capital Management LLC lifted its position in shares of Hims & Hers Health, Inc. (NYSE:HIMS – Free Report) by 34.9% during the 4th quarter, HoldingsChannel.com reports. The fund owned 896,020 shares of the company’s stock after acquiring an additional 231,867 shares during the quarter. Hims & Hers Health makes up about 1.0% of Mckinley […]
Jefferies Financial Group reiterated their hold rating on shares of Hims & Hers Health (NYSE:HIMS – Free Report) in a report issued on Tuesday, Marketbeat.com reports. They currently have a $15.00 target price on the stock, down from their prior target price of $17.00. HIMS has been the subject of a number of other reports. […]
Algert Global LLC boosted its stake in shares of Hims & Hers Health, Inc. (NYSE:HIMS – Free Report) by 22.1% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 187,550 shares of the company’s stock after buying an additional 33,960 shares during the […]
Hims & Hers Health (NYSE:HIMS – Get Free Report) posted its earnings results on Monday. The company reported ($0.03) EPS for the quarter, beating the consensus estimate of ($0.06) by $0.03, Briefing.com reports. Hims & Hers Health had a negative return on equity of 18.97% and a negative net margin of 9.65%. The firm had […]